seed
Stage
3
Investors
About
Marrabio develops engineered Caf1 proteins as a cost-effective, stable alternative to traditional bioactive proteins for use in biomedical research, cultivated meat production, and other life sciences applications.
Explore Marrabio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.